AIM
GHDX

Alambic Investment Management’s Genomic Health, Inc. GHDX Stock Holding History

Alambic Investment Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,200
Closed -$665K – 418
2018
Q2 		$665K Sell
13,200
-8,400
-39% -$333K 0.18% 174
2018
Q1 		$676K Buy
+21,600
New +$717K 0.09% 283

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Alambic Investment Management's GHDX Position: Q3 2018 in Review

Alambic Investment Management sold out of Genomic Health, Inc. (GHDX) in Q3 2018, closing a stake of 13,200 shares — an estimated $665K sold.

Alambic Investment Management first reported a position in GHDX in Q1 2018 and held it in 2 quarters. The position peaked at $676K in Q1 2018. 201 funds tracked by Wall St. Rank hold GHDX as of Q3 2018.

  • Alambic Investment Management reported no remaining Genomic Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Alambic Investment Management sold 13,200 Genomic Health, Inc. shares in Q3 2018, an estimated $665K.
  • Alambic Investment Management first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 2 quarters.
  • Alambic Investment Management's Genomic Health, Inc. position peaked at $676K in Q1 2018.
  • 201 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2018.

Based on Alambic Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.